Sushil Patel, Director at Revolution Medicines, Inc. (RVMD), sold 5,580 shares at $183.17 ($1.0M) on 2026-06-29, disclosed to the SEC on 2026-07-01.
Scheduled sale ($1.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $183.17 | 300 | $55K | 5.2% |
| 2 | $184.59 | 900 | $166K | 15.8% |
| 3 | $185.90 | 1,100 | $204K | 19.5% |
| 4 | $186.92 | 858 | $160K | 15.3% |
| 5 | $187.83 | 300 | $56K | 5.4% |
| 6 | $188.57 | 100 |
| $19K |
| 1.8% |
| 7 | $190.54 | 600 | $114K | 10.9% |
| 8 | $191.87 | 541 | $104K | 9.9% |
| 9 | $192.61 | 881 | $170K | 16.2% |
| Total | $187.99 avg | 5,580 | $1.0M | 100% |
| Filing → |
| REPL | SELL | 2025-12-04 | $223K | — | Filing → |
| REPL | SELL | 2025-05-22 | $405K | — | Filing → |
| REPL | SELL | 2024-12-18 | $124K | — | Filing → |